Schoenberg Mark

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Everything we currently hold fits inside that, so nothing is being held back here today. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

Filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
UroGen Pharma Ltd.Chief Medical OfficerOption exercisenothing paid1,667 sharesSep 9, 2026UroGen Pharma Ltd.Chief Medical Officernothing paidExercise · Sep 9Option exercise1,667Sep 9, 2026
UroGen Pharma Ltd.Chief Medical OfficerOpen-market sell$37,383871 sharesSep 9, 2026UroGen Pharma Ltd.Chief Medical Officer$37,383Sell · Sep 9Open-market sell871Sep 9, 2026
UroGen Pharma Ltd.Chief Medical OfficerOption exercise—1,667 sharesSep 9, 2026UroGen Pharma Ltd.Chief Medical Officer—Exercise · Sep 9Option exercise1,667Sep 9, 2026
UroGen Pharma Ltd.Chief Medical OfficerOpen-market sell$2,854,85360,677 sharesAug 24, 2026UroGen Pharma Ltd.Chief Medical Officer$2,854,853Sell · Aug 24Open-market sell60,677Aug 24, 2026
UroGen Pharma Ltd.Chief Medical OfficerOpen-market sell$400,00010,000 sharesJul 10, 2026UroGen Pharma Ltd.Chief Medical Officer$400,000Sell · Jul 10Open-market sell10,000Jul 10, 2026